title: Psychological distress symptoms in women undergoing medical vs. surgical termination of pregnancy.
abstract: OBJECTIVE
  The purpose of this study is to compare the baseline psychological distress and symptom profile of women undergoing either medical (with mifepristone) or surgical pregnancy termination and the psychological outcome 2 weeks after the procedure.
  
  
  METHODS
  Women (n = 200) given free choice of pregnancy termination method, either medical or surgical, were assessed before pregnancy termination by a demographic questionnaire including questions regarding the choice of the method of pregnancy termination, the Brief Symptom Inventory (BSI), the Spielberger State Anxiety questionnaire and the Rotter Locus of Control Scale. Two weeks after the procedure, the BSI and Spielberger questionnaires were repeated.
  
  
  RESULTS
  Women with a smaller number of past pregnancies tended to choose the medical procedure. Reasons for choosing the medical procedure were fear of surgery, anesthesia and of future fertility difficulties. Prior to the procedure, the "medical group" had significantly higher levels of obsessive-compulsive symptoms, guilt and BSI general symptom index score, and a trend for higher interpersonal sensitivity and paranoid ideation. Postprocedure, both groups showed significant decline in anxiety levels and did not differ on most symptom parameters.
  
  
  CONCLUSIONS
  Women who chose to have a medical termination are marginally more symptomatic before the procedure than women choosing surgical termination. However, both methods of pregnancy termination resulted in significant reduction in preabortion psychological distress level.
authors.affiliation: Department of Obstetrics and Gynecology, the Rappaport Technion Faculty of Medicine, Rambam Medical Center, POB 9602, Haifa 31096, Israel. l_lior@rambam.health.gov.il
authors.forename: Lior
authors.initials: L
authors.lastname: Lowenstein
authors.forename: Michael
authors.initials: M
authors.lastname: Deutcsh
authors.forename: Rakefet
authors.initials: R
authors.lastname: Gruberg
authors.forename: Ido
authors.initials: I
authors.lastname: Solt
authors.forename: Yaron
authors.initials: Y
authors.lastname: Yagil
authors.forename: Ori
authors.initials: O
authors.lastname: Nevo
authors.forename: Miki
authors.initials: M
authors.lastname: Bloch
mesh_terms: D000019:Abortifacient Agents; D000028:Abortion, Induced / Q000379:methods / Q000523:psychology*; D000328:Adult; D000527:Alprostadil / Q000031:analogs & derivatives; D001007:Anxiety / Q000209:etiology*; D002755:Choice Behavior; D005260:Female; D006801:Humans; D015735:Mifepristone; D017060:Patient Satisfaction; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011446:Prospective Studies; D011459:Prostaglandins E, Synthetic; D013315:Stress, Psychological / Q000209:etiology; D011795:Surveys and Questionnaires
chemical_list: D000019:Abortifacient Agents; D011459:Prostaglandins E, Synthetic; D015735:Mifepristone; C021182:gemeprost; D000527:Alprostadil